Skip to main content
Equibles
TNON logo

TNON · Tenon Medical, Inc. · Metrics

Track TNON — free

Use TNON with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research TNON.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$3.62 -0.08 (-2.16%) At close · Oct 5
Rebalance outlook locked
Going-concern doubt — flagged Aug 13, 2026

Substantial doubt about the company's ability to continue as a going concern.

“There is substantial doubt about the Company's ability to continue as a going concern for one year after the date that these financial statements are issued.”
View the 10-Q filed Aug 13, 2026
Market Cap
$2.09M
Shares
667,047
Volume · Oct 5 463.67K Avg daily vol (39 sessions) 10.46M

TNON metrics

47 of 115 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$3.70
Market cap
$2.09M

Price action

20 metrics
Price change (1W)
+18.2%
Price change (30D)
+10.1%
Price change (3M)
—
Price change (6M)
—
Price change (YTD)
—
Price change (1Y)
—
Trailing year
Price change (5Y)
—
52-week high
—
52-week low
—
Change from 52-week high
—
Change from 52-week low
—
Annualized volatility
—
Annualized volatility (3M)
—
Beta
—
RSI (14D)
46.9
Price vs SMA 50
—
Price vs SMA 200
—
Avg volume (3M)
10.46M
Relative volume
0.6
Average dollar volume
$61.74M

Company

3 metrics
Sector
Healthcare
Industry
Medical Devices
Shares outstanding
667,047

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
0.4×
reciprocal yield 254.4%
P / book
—
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-656.0%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-08-13

Profitability

9 metrics
Gross margin
66.8%
Operating margin
-242.7%
Trailing 12 months
Net margin
-257.9%
Gross profit (TTM)
$3.55M
Operating profit (TTM)
−$12.89M
Net income (TTM)
−$13.70M
Trailing 12 months
Diluted EPS (TTM)
$-83.59
FCF margin
—
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$568.97

Growth

11 metrics
Revenue growth YoY
+126.8%
Year over year
Net income growth YoY
—
Revenue (TTM)
$5.31M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+51.2%
Year over year · more shares
Revenue CAGR (3Y)
+78.7%
Revenue CAGR (5Y)
—
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
—
Return on assets
-138.0%
Debt / equity
—
Current ratio
0.6
EBITDA (TTM)
−$12.57M
Free cash flow (TTM)
—
Quick ratio
0.5
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$1.68M
Total assets
$9.92M
Total debt
—

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$11.77M
Capital expenditures (TTM)
$309,000
R&D (TTM)
$2.38M
SG&A (TTM)
—
Stock compensation (TTM)
$1.15M
R&D / revenue
44.9%
Stock compensation / revenue
21.6%

Ownership (13F)

3 metrics
13F filers
22
13F filer change QoQ
+1
Institutional ownership
33.0%

Short interest

3 metrics
Short interest
80.8%
Latest settlement · 1.0 days to cover
Days to cover
1.0d
Short-squeeze score
59 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$105,445
Insider-sentiment score
42 / 100

Risk flags

1 metrics
Going concern
Flagged
Key facts CIK 1560293 CUSIP 88066N402 Visit website Investor relations